Navigation Links
United States Patent and Trademark Office Accepts CoolTouch's Re-examination Request for Cynosure '873 Patent
Date:6/2/2009

On May 22, 2009 the United States Patent & Trademark Office (USPTO) accepted CoolTouch's request to re-examine the '873 Paolini laser lipolysis patent based on prior art by Dr. David Apfelberg and Mr. David Hennings.

Roseville, CA (PRWEB) June 2, 2009 -- On May 22, 2009 the United States Patent & Trademark Office (USPTO) accepted CoolTouch's request to re-examine the '873 Paolini laser lipolysis patent based on prior art by Dr. David Apfelberg and Mr. David Hennings. As a result, CoolTouch Inc. has petitioned the court for a motion to stay the litigation regarding this patent between CoolTouch and Cynosure.

CoolTouch CEO, David R. Hennings states " The Patent office's rapid response to our request supports CoolTouch's contention that the '873 Paolini patent is invalid. I hope that they rule on the strong merits of our case just as quickly so we may see this litigation end soon. With this new ruling, the Court will certainly accept our motion for stay and we expect they will also approve our motion for summary judgment that the '873 patent is invalid."

The CoolTouch CoolLipo™ 1320 wavelength laser was designed to be superior to the Cynosure SmartLipo 1064 laser technology and does not infringe Cynosure's '873 Paolini patent involving laser-assisted lipolysis. The CoolLipo incorporates state-of-the-art 1320 nm laser technology, coated fibers, and a variety of handpieces which allow the fiber to be extended beyond the end of the cannula, thereby not infringing the '873 patent whose claims require that the fiber must be adjacent to the end of the cannula. The CoolTouch advantage of extending the fiber beyond the cannula helps prevent inadvertent heating of the cannula and assists in cutting connective tissue. On December 22, 2008 the court's Markman ruling rejected Cynosure's attempts to define "adjacent" to mean "in the vicinity of" the
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Tim McGraw and Faith Hill Join Senior Military for Country United: Advancing Medicine From the Frontlines to the Homefront
2. Americans United for Life: Obama Nominates Avowed Judicial Activist Judge Who Undermines Common Ground
3. Americans United for Life on Sotomayor Nomination
4. Bill Saunders Joins Americans United for Life, Set to Expand Efforts to Protect Human Life Internationally
5. Americans United for Life Memo Urges Senators to Consider New Abortion Polling Data Showing Majorities of all Parties Oppose Judicial Activism, Support Abortion Regulations
6. United Spinal Associations 2nd Annual Disability Leadership & Policy Summit: Health Issues and People with Disabilities
7. Americans United for Life Announces Legal Prospectus on Probable Supreme Court Nominees
8. United Concordia and Texas Oral Health Coalition Partner to Offer Free Dental Services
9. UnitedHealthcare Childrens Foundation To Award More Medical Grants for Child Health Care Needs in New Jersey
10. UnitedHealthcare Childrens Foundation To Award More Medical Grants for Child Health Care Needs in Connecticut
11. .decimal, Inc. Gains 510k Clearance from the FDA to Market its p.d(TM) Software for Bolus Electron Conformal Therapy in the United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... Texas (PRWEB) May 24, 2013 This ... 2022” provides an overview of the risk factors and ... (8MM) (US, France, Germany, Italy, Spain, UK, Australia, and ... cases of meningococcal disease segmented by age (<1, 1–4, ... (B, C, Y, and W-135) in these markets. The ...
(Date:5/24/2013)... PA (PRWEB) May 24, 2013 Patients ... be more likely to suffer from gastroesophageal reflux disease ... physicians reported in a study published today. , The ... Abnormal Proximal Exposure as Measured by Hypopharyngeal Multichannel Intraluminal ... findings could be of great importance to individuals who ...
(Date:5/24/2013)... 24, 2013 Ten Seattle’s Best Coffee ... stores were fabricated and installed over the last 3 ... Palomar Modular Buildings . , “The custom specifications for ... They made a conscious decision to utilize the modular ... with the build quality they wanted, and their plan ...
(Date:5/24/2013)... have today released updated guidelines on Hormone Replacement Therapy ... the benefits and the risks. The new guidelines appear ... published by SAGE. , Over the last 11 ... of youth" to being considered extremely risky and only ... of the Women,s Health Initiative (WHI) trial in 2002, ...
(Date:5/24/2013)... 2013 http://www.resource4thepeople.com/defectivedrugs/Zithromax-lawsuits.html , ... update involving allegations that the use of the ... allegedly cause potentially fatal irregular heart rhythms. ... 17, 2013* that Health Canada has joined the ... Zithromax can cause abnormal changes in the electrical ...
Breaking Medicine News(10 mins):Health News:Meningococcal Disease Market Analysis and 2022 Forecasts in New Research Report at RnRMarketResearch.com 2Health News:Meningococcal Disease Market Analysis and 2022 Forecasts in New Research Report at RnRMarketResearch.com 3Health News:Meningococcal Disease Market Analysis and 2022 Forecasts in New Research Report at RnRMarketResearch.com 4Health News:West Penn Allegheny Health System Physicians Pinpoint Gastroesophageal Reflux Disease (GERD) as a Factor That May Cause Chronic Cough 2Health News:Seattle’s Best Coffee Gets Modular 2Health News:2013 Alleged Zithromax Arrhythmia and Sudden Death Cases Update: Canadian Health Officials Issue Warning 2Health News:2013 Alleged Zithromax Arrhythmia and Sudden Death Cases Update: Canadian Health Officials Issue Warning 3Health News:2013 Alleged Zithromax Arrhythmia and Sudden Death Cases Update: Canadian Health Officials Issue Warning 4
... growing challenge, researchers say , , FRIDAY, Aug. 1 (HealthDay ... in countries with high rates of multi-drug resistant (MDR) ... Health Organization data from 2003 to 2004 for ... MDR-TB, patients are nearly twice as likely to fail ...
... WASHINGTON, August 1 Mark Merritt, President,of ... following,statement in response to new comparative effectiveness ... Committee Chair Max Baucus,(D-Mont.) and Senate Budget ... applaud Senators Baucus and Conrad for helping ...
... SAN FRANCISCO, CA The August issue of Ophthalmology, ... includes surprising findings on Asian ethnicity and macular degeneration ... a study of successful treatments for ocular surface cancer. ... Population , AMD erodes and can eventually destroy the ...
... nutritional supplement renowned for enhancing athletic performance and ... patients with chronic obstructive pulmonary disease (COPD), according ... study provided the most powerful evidence to date ... negligible at best among these patients. , "We ...
... in the document scanning industry, announced that its ... http://www.imagedocusa.com . The site introduces a ... businesses to "Go Paperless!" ImageDoc USA, headquartered ... and has created a reputation as a niche ...
... in the August 2008 edition of Otolaryngology ... medical community to develop a national consensus on ethical ... casualties of disasters such as hurricanes, tornadoes, floods, or ... Academy of Otolaryngology-Head and Neck Surgery,s Ethics Committee Chair, ...
Cached Medicine News:Health News:Drug Resistance Is Slowing Global Fight Against TB 2Health News:Highlights from the August 2008 issue of Ophthalmology 2Health News:Highlights from the August 2008 issue of Ophthalmology 3Health News:Highlights from the August 2008 issue of Ophthalmology 4Health News:No substitute for hard work: Creatine supplementation does not improve exercise outcomes in COPD 2Health News:ImageDoc USA, Inc. Launches "Go Paperless!" Website 2
(Date:5/23/2013)... , May 23, 2013  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... been named the 2013 Life Science Firm of the Year ... (TCM).  Vanda was honored at the TCM,s 25 th ... , Maryland.  The Tech Awards Celebration recognizes the leaders and ... Maryland and the surrounding regions. ...
(Date:5/23/2013)... May 23, 2013 Nephros, Inc. (OTC Bulletin ... device company that develops and sells high performance liquid ... rights offering.  In addition, the concurrent temporary reduction in ... on May 17, 2013. Nephros estimates that ... the rights offering.   A portion of the proceeds will ...
(Date:5/23/2013)...  Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), ... on intellectual property developed and owned by Hadassah ... medical research center, today announced that its portfolio ... from the Israeli Ministry of Industry and Commerce, ... product development and advance clinical trials. Cell Cure,s ...
Breaking Medicine Technology:Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland 2Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2
... DETROIT , March 11 Caraco ... launched oxaliplatin injections. These 50mg and 100mg oxaliplatin injections, ... approval from the US Food and Drug Administration (FDA) ... is an anticancer used in the treatment of colon ...
... today the commercial launch of its new VivoTag ® 680 XL fluorescent dye for labeling biomolecules in a broad range of ... ... ... ...
Cached Medicine Technology:Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Eloxatin(R) 2Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Eloxatin(R) 3VisEn Launches New VivoTag(R) 680 XL Fluorescence Molecular Imaging Label 2VisEn Launches New VivoTag(R) 680 XL Fluorescence Molecular Imaging Label 3VisEn Launches New VivoTag(R) 680 XL Fluorescence Molecular Imaging Label 4
... is the first truely web-based solution on the ... POC (managed from the lab) and Critical Care ... of AegisPOC ensures that all groups have the ... in the manner best suited to them. Through ...
...
... The Vari-Lase Endovenous Laser System is ... for varicose veins in the leg. Endovenous ... surgical vein-stripping for the treatment of varicose ... laser fiber is inserted into the varicosed ...
Using proven 1064 nm technology for the treatment of deeper lesions, the Lumenis One Multi-Spot Nd:YAG module provides versatility allowing targeted treatment of leg veins, vascular lesions, facial w...
Medicine Products: